The Kineticos Difference

Kineticos invests in entrepreneurs and early-stage companies, providing deep expertise, industry knowledge, and a bench of proven experts to support them through
every stage of their life cycle.

Investment Focus

We partner with companies that offer unique, innovative, and IP-protected products and services with a focus on cell and gene therapy, oncology, neurosciences, rare diseases, and antimicrobial resistance (AMR).

Learn More

Contract Services & Enabling Technologies

 

Invest in CDMOs, equipment, and enabling technology companies

Antimicrobial Resistance

 

Invest in novel therapies, services, vaccine and diagnostic companies

Biotech & Medtech

 

Invest in advanced therapeutic and medical device companies

Foundry

 

Form new companies to advance science and drug development

Learn More

Portfolio Highlights

Explore our diverse and cutting-edge portfolio.

See Portfolio
kineticos.homepage.team_240111

Team Overview

Kineticos is led by life sciences industry entrepreneurs, operators and investors with scientific, business, and operating expertise who have exited companies.

Our Team

New From Kineticos

Press Release
July 26, 2023

Kincell Bio Launches

Cell therapy CDMO spins out of Inceptor Bio to help innovators develop and manufacture life-saving cell therapies RALEIGH, N.C., AND…

View All

Get Started with Kineticos

Let’s accelerate your progress together.

Contact Us